The use of low-dose radiotherapy may offer transient benefits; nonetheless the potential for palliative care exists.
Vivek N. Patel, MD
Advertisement
Articles by Vivek N. Patel, MD
Advertisement
Latest Updated Articles
A Phase II Trial of Cetuximab and Docetaxel With Radiation for Head and Neck CancerPublished: April 20th 2017 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
